Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F6OK
|
|||
| Former ID |
DNC002814
|
|||
| Drug Name |
N-Methylleucine
|
|||
| Synonyms |
N-Methyl-L-leucine; 3060-46-6; (S)-4-Methyl-2-(methylamino)pentanoic acid; N-Methylleucine; L-Leucine, N-methyl-; N-Me-Leu-OH; MeLeu; methyl-L-leucine; UNII-2YT9687ECD; 2YT9687ECD; H-ALPHA-METHYL-L-LEUCINE; AK107655; N-methyl-l-leu; Leucine, N-methyl-; AC1MCSAQ; SCHEMBL93452; AMGLY00163; CTK1A1168; MolPort-003-925-252; XJODGRWDFZVTKW-LURJTMIESA-N; ZINC160405; KS-00000J9G; FCH835634; ANW-74881; AKOS006282756; CS-W008140; ACM3060466; AJ-15591; SC-82208; KB-58630; AC-24158; AS-19192; DB-038132; TC-163626; AX8020112; X5243; ST24036190; FT-0695191
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H15NO2
|
|||
| Canonical SMILES |
CC(C)CC(C(=O)O)NC
|
|||
| InChI |
1S/C7H15NO2/c1-5(2)4-6(8-3)7(9)10/h5-6,8H,4H2,1-3H3,(H,9,10)/t6-/m1/s1
|
|||
| InChIKey |
XJODGRWDFZVTKW-ZCFIWIBFSA-N
|
|||
| CAS Number |
CAS 31321-74-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
7888937, 10701720, 16032248, 24845360, 39874497, 50907505, 91688343, 111396529, 119503059, 129698068, 132565383, 137039613, 142548090, 144220660, 160842379, 162160512, 162495935, 163405533, 164848071, 179683924, 202538309, 204429697, 223524762, 224511676, 226471240, 241085352, 249855777, 250213849, 252068123, 252374479, 252376553, 252400575, 252447337, 252552374
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | C-X-C motif chemokine 10 (CXCL10) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| Chemokine signaling pathway | ||||
| Toll-like receptor signaling pathway | ||||
| RIG-I-like receptor signaling pathway | ||||
| Cytosolic DNA-sensing pathway | ||||
| TNF signaling pathway | ||||
| Influenza A | ||||
| NetPath Pathway | IL-7 Signaling Pathway | |||
| TSLP Signaling Pathway | ||||
| TNFalpha Signaling Pathway | ||||
| TWEAK Signaling Pathway | ||||
| TCR Signaling Pathway | ||||
| Panther Pathway | Inflammation mediated by chemokine and cytokine signaling pathway | |||
| Pathway Interaction Database | CXCR3-mediated signaling events | |||
| Reactome | Chemokine receptors bind chemokines | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Toll-like receptor signaling pathway | |||
| Type II interferon signaling (IFNG) | ||||
| Spinal Cord Injury | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| Regulation of toll-like receptor signaling pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.